SLRX
Salarius Pharmaceuticals Inc
NASDAQ: SLRX · HEALTHCARE · BIOTECHNOLOGY
$0.84
+29.23% today
Updated 2026-01-07
Market cap
$4.92M
P/E ratio
—
P/S ratio
18.12x
EPS (TTM)
$-24.24
Dividend yield
—
52W range
$1 – $25
Volume
2.4M
Salarius Pharmaceuticals Inc (SLRX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
-14.6%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+84.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-24.0%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-24.0%
2025-11-14
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-14 | $-1.81 | -79.2% | $1.21 | $0.92 | -24.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $-1.01 | $-1.81 | -79.2% | — | — |
| 2025-06-30 | $-1.02 | $-0.45 | +55.9% | — | — |
| 2025-03-31 | $-1.03 | $-1.02 | +1.4% | — | — |
| 2024-12-31 | $-0.74 | $-1.01 | -36.5% | $4426.00 | -75.3% |
| 2024-09-30 | $-804.00 | $-11.40 | +98.6% | — | — |
| 2024-06-30 | $-53.60 | $-2.37 | +95.6% | — | — |
| 2024-03-31 | $-6.70 | $-0.41 | +93.9% | — | — |
| 2023-12-31 | $-1.01 | $-0.22 | +78.2% | $17892.00 | — |
| 2023-09-30 | $-1.20 | $-0.65 | +45.8% | — | — |
| 2023-06-30 | $-1.30 | $-1.43 | -10.0% | — | — |
| 2023-03-31 | $-2.50 | $-2.23 | +10.8% | — | — |
| 2022-12-31 | $-2.15 | $-2.83 | -31.6% | — | — |
Frequently asked questions
Has Salarius Pharmaceuticals Inc beaten earnings estimates?
Salarius Pharmaceuticals Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of -14.6% over the last 4 quarters.
How does SLRX stock react to earnings?
SLRX stock has moved an average of -24.0% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.